Stay updated on GB002 Open-Label Extension in PAH Clinical Trial
Sign up to get notified when there's something new on the GB002 Open-Label Extension in PAH Clinical Trial page.
Latest updates to the GB002 Open-Label Extension in PAH Clinical Trial page
- Check2 days agoChange DetectedNo changes to core study data were detected; only minor UI adjustments in the page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a dedicated Locations section with detailed site entries across multiple states and countries, and removed prior state-level location groupings.SummaryDifference1%
- Check24 days agoChange DetectedThe screenshots show the same Study Details page for NCT04816604 with no additions or deletions to core sections; minor visual tweaks may be present but do not alter the study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check31 days agoChange DetectedNo significant changes to the study record were observed. Updates seem to be routine informational additions, such as new publications, and minor formatting changes.SummaryDifference0.1%
- Check38 days agoChange DetectedThe study locations have been updated to 28 sites, with Oregon Health & Science University (Portland, OR) and Lundquist Institute at Harbor-UCLA (Torrance, CA) removed from the list.SummaryDifference0.4%
- Check45 days agoChange DetectedPublications section description updated to reflect that publications are automatically filled in from PubMed, using revised wording. Page revision tag updated from v3.2.0 to v3.3.2.SummaryDifference0.1%
Stay in the know with updates to GB002 Open-Label Extension in PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB002 Open-Label Extension in PAH Clinical Trial page.